Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Sequester Withholding of FDA User Fees Irks Drug and Medical Device Makers

Washington, DC, May 21, 2013Roll Call reports that, for years, makers of drugs and medical devices have paid the Food and Drug Administration (FDA) in exchange for the agency committing to certain performance goals, including evaluating submitted drugs, therapies and technologies before they may be introduced into the marketplace.  

But now, Roll Call reports, the FDA may not be able to accomplish all those goals, because some of the funds are being cut by the sequester.  

More specifically, companies that make drugs and devices continue to pay the full amount established in the latest user fee reauthorization, which was passed in 2012.  However, the money now is subject to the sequester cuts at the same level as the rest of the FDA’s budget authority.  That means that portion of the user fees — $83 million, according to the agency — is being sliced off and is unavailable to the FDA.

Lawmakers now are working to give the FDA the flexibility to access all funds it receives from private companies.

To read the complete Roll Call article, click here.